Amanote Research
Register
Sign In
Tumor Suppressor NDRG2 Tips the Balance of Oncogenic TGF-β via EMT Inhibition in Colorectal Cancer
Oncogenesis
- United States
doi 10.1038/oncsis.2013.48
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Molecular Biology
Date
February 1, 2014
Authors
L Shen
X Qu
Y Ma
J Zheng
D Chu
B Liu
X Li
M Wang
C Xu
N Liu
L Yao
J Zhang
Publisher
Springer Science and Business Media LLC
Related search
TGF-β Antagonists: Why Suppress a Tumor Suppressor?
Journal of Clinical Investigation
Medicine
Mutated in Colorectal Cancer, a Putative Tumor Suppressor for Serrated Colorectal Cancer, Selectively Represses Β-Catenin-Dependent Transcription
Oncogene
Cancer Research
Genetics
Molecular Biology
TGF-β Switches From Tumor Suppressor to Prometastatic Factor in a Model of Breast Cancer Progression
Journal of Clinical Investigation
Medicine
TGF-β Secreted by Tumor-Associated Macrophages Promotes Proliferation and Invasion of Colorectal Cancer via miR-34a-VEGF Axis
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
The Diverse Oncogenic and Tumor Suppressor Roles of microRNA-105 in Cancer
Frontiers in Oncology
Cancer Research
Oncology
DDX3 Enhances Oncogenic KRAS‑induced Tumor Invasion in Colorectal Cancer via the Β‑catenin/Zeb1 Axis
Oncotarget
Oncology
TAp73 Increases P53 Tumor Suppressor Activity in Thyroid Cancer Cells via the Inhibition of Mdm2-Mediated Degradation
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
TGF-β Family Signaling in Tumor Suppression and Cancer Progression
Cold Spring Harbor perspectives in biology
Biochemistry
Genetics
Molecular Biology
The Tumor Suppressor miR-138-5p Targets PD-L1 in Colorectal Cancer
Oncotarget
Oncology
